TAKEDA PHARMACEUTICAL CO LTD's ticker is and the CUSIP is 874060955. A total of 3 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $58 | -60.3% | 3,700 | -58.4% | 0.00% | – |
| Q1 2023 | $146 | +356.2% | 8,900 | +323.8% | 0.00% | – |
| Q4 2022 | $32 | -100.0% | 2,100 | -61.1% | 0.00% | – |
| Q3 2022 | $70,000 | +677.8% | 5,400 | +671.4% | 0.00% | – |
| Q2 2022 | $9,000 | -91.4% | 700 | -90.5% | 0.00% | – |
| Q1 2022 | $105,000 | -37.9% | 7,400 | -40.3% | 0.00% | – |
| Q4 2021 | $169,000 | -73.9% | 12,400 | -67.7% | 0.00% | -100.0% |
| Q3 2021 | $648,000 | +0.3% | 38,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $646,000 | -65.3% | 38,400 | +3664.7% | 0.00% | -66.7% |
| Q1 2021 | $1,862,000 | +272.4% | 1,020 | +270.9% | 0.00% | +200.0% |
| Q4 2020 | $500,000 | -10.4% | 275 | -12.1% | 0.00% | 0.0% |
| Q3 2020 | $558,000 | -2.3% | 313 | -1.9% | 0.00% | 0.0% |
| Q2 2020 | $571,000 | +22.0% | 319 | +3.2% | 0.00% | 0.0% |
| Q1 2020 | $468,000 | – | 309 | -27.3% | 0.00% | – |
| Q4 2019 | $0 | – | 425 | +18.7% | 0.00% | – |
| Q3 2019 | $0 | – | 358 | -3.2% | 0.00% | – |
| Q2 2019 | $0 | – | 370 | -0.3% | 0.00% | – |
| Q1 2019 | $0 | – | 371 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JPMORGAN CHASE & CO | 365,178 | $7,439,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 10,300 | $210,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 371 | $0 | 0.00% |